These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 830416)

  • 21. On the influence of chloramphenicol on the induction of lung adenomas by urethane in mice.
    Shabad LM; Bogush TA; Belitsky GA
    Neoplasma; 1975; 22(4):347-54. PubMed ID: 1196420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice.
    Giuliani FC; Coirin AK; Rice MR; Kaplan NO
    Cancer Treat Rep; 1981; 65(11-12):1063-75. PubMed ID: 7296552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of commercial saccharin preparations on urethan-induced lung tumorigenesis in strain A mice.
    Theiss JC; Arnold LJ; Shimkin MB
    Cancer Res; 1980 Nov; 40(11):4322-4. PubMed ID: 7471070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.
    Barranco SC; Novak JK
    Cancer Res; 1974 Jul; 34(7):1616-8. PubMed ID: 4858112
    [No Abstract]   [Full Text] [Related]  

  • 27. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of pulmonary adenomas in strain A mice by substituted organohalides.
    Theiss JC; Shimkin MB; Poirier LA
    Cancer Res; 1979 Feb; 39(2 Pt 1):391-5. PubMed ID: 761210
    [No Abstract]   [Full Text] [Related]  

  • 29. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.
    Boven E; Winograd B; Berger DP; Dumont MP; Braakhuis BJ; Fodstad O; Langdon S; Fiebig HH
    Cancer Res; 1992 Nov; 52(21):5940-7. PubMed ID: 1394220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular cohesive forces in the pulmonary tissue of different lines of mice and their sensitivity to induction of lung tumors by urethane].
    Modianova EA
    Vopr Onkol; 1973; 19(6):83-8. PubMed ID: 4778565
    [No Abstract]   [Full Text] [Related]  

  • 32. The antineoplastic activity of 4'-deoxydoxorubicin in murine solid tumors.
    Marmonti L; Jin XQ; Filippeschi S; Spreafico F
    Anticancer Res; 1984; 4(6):425-9. PubMed ID: 6517535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between urethan dose rate and adenoma latency: relevance of tumor growth rate and target cell number.
    O'Flaherty EJ; Dourson ML
    J Natl Cancer Inst; 1982 Oct; 69(4):859-65. PubMed ID: 6956763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human tumor testsystems: a new screening approach.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1986 Jun; (80):103-12. PubMed ID: 3753367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors.
    Shrivastav S; Bonar RA; Stone KR; Paulson DF
    Cancer Res; 1980 Dec; 40(12):4438-42. PubMed ID: 7438075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.
    Begg AC; Fu KK; Kane LJ; Phillips TL
    Cancer Res; 1980 Jan; 40(1):145-54. PubMed ID: 7349894
    [No Abstract]   [Full Text] [Related]  

  • 40. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.